Menu
Back to User profile » Professor Felix Herth
Papers published by Professor Felix Herth:
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJ, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2039-2054
Published Date: 15 September 2023
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1431-1444
Published Date: 13 July 2023
Endobronchial Valve Replacements in Patients with Advanced Emphysema After Endoscopic Lung Volume Reduction
Brock JM, Schuster PU, Böhmker F, Eberhardt R, Gompelmann D, Kontogianni K, Trudzinski F, Benjamin N, Herth F
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:933-943
Published Date: 19 May 2023
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:643-659
Published Date: 19 April 2023
Inhaled Steroids, Sex and Emphysema Index – Clinical Parameters with Impact on the Effectiveness of Valve Implantation in Patients with Severe Emphysema
Polke M, Brugger J, Rötting M, Polke N, Brock J, Schuler S, Richter I, Eberhardt R, Herth FJF, Gompelmann D
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1423-1430
Published Date: 20 June 2022
Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD
Abdo M, Pedersen F, Trinkmann F, Herth FJF, Rabe KF, Kirsten AM, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1403-1408
Published Date: 17 June 2022
Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
Herth FJF, Sandhaus RA, Turner AM, Sucena M, Welte T, Greulich T
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2983-2996
Published Date: 1 November 2021
Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H
Journal of Asthma and Allergy 2020, 13:605-614
Published Date: 11 November 2020
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
Valipour A, Shah PL, Herth FJ, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Conway F, Duller M, Mayse M, Norman HS, Slebos DJ
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2807-2816
Published Date: 5 November 2020
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, El Shafie RA, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S
Cancer Management and Research 2018, 10:6563-6569
Published Date: 30 November 2018
Clinical and quantitative computed tomography predictors of response to endobronchial lung volume reduction therapy using coils
Kontogianni K, Russell K, Eberhardt R, Schuhmann M, Heussel CP, Wood S, Herth FJ, Gompelmann D
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2215-2223
Published Date: 20 July 2018
New bacterial growth in bronchial secretions after bronchoscopic valve implantation
Sarmand N, Gompelmann D, Kontogianni K, Polke M, Herth FJF, Eberhardt R
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:565-570
Published Date: 8 February 2018
The minimal important difference for target lobe volume reduction after endoscopic valve therapy
Gompelmann D, Kontogianni K, Schuhmann M, Eberhardt R, Heussel CP, Herth FJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:465-472
Published Date: 1 February 2018
Coil therapy for patients with severe emphysema and bilateral incomplete fissures – effectiveness and complications after 1-year follow-up: a single-center experience
Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Hoffmann H, Heussel CP, Herth FJF, Eberhardt R
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:383-394
Published Date: 23 January 2017
Clinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves
Gompelmann D, Benjamin N, Kontogianni K, Herth FJF, Heussel CP, Hoffmann H, Eberhardt R
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3093-3099
Published Date: 7 December 2016
Significant lung volume reduction with endobronchial valves in a patient despite the presence of microcollaterals masked by low-flow Chartis phenotype
Yin Y, Hou G, Herth FJ, Wang X, Wang Q, Kang J
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2913-2917
Published Date: 24 November 2016
Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema
Gompelmann D, Lim H, Eberhardt R, Gerovasili V, Herth FJF, Heussel CP, Eichinger M
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1767-1773
Published Date: 1 August 2016
Endoscopic bronchial valve treatment: patient selection and special considerations [Corrigendum]
Eberhardt R, Gompelmann D, Herth FJF, Schuhmann M
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2675-2676
Published Date: 18 December 2015
Endoscopic bronchial valve treatment: patient selection and special considerations
Eberhardt R, Gompelmann D, Herth FJF, Schuhmann M
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2147-2157
Published Date: 8 October 2015
Technology update: bronchoscopic thermal vapor ablation for managing severe emphysema
Gompelmann D, Eberhardt R, Herth FJF
Medical Devices: Evidence and Research 2014, 7:335-341
Published Date: 30 September 2014
Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema
Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, Stanzel F, Valipour A, Wagner M, Witt C, Kesten S, Snell G
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:397-405
Published Date: 18 July 2012